The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Share News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cenkos Securities Falls To Interim Loss As It Reduces Execs On Board

Wed, 18th Sep 2019 10:38

(Alliance News) - Cenkos Securities PLC on Wednesday reported an interim loss, sinking from profit a year before, as the stockbroker announced its head of equity capital markets and natural resources will step down from the board but remain in their executive roles.

Shares in the stockbroker were 17% higher in London in mid-morning trade at 52.00 pence each.

In the six months to June 30, Cenkos sunk to a pretax loss of GBP196,000 compared to a GBP464,000 profit the year before.

The stockbroker's revenue declined 41% to GBP10.6 million from GBP18.1 million a year before. Cenkos's total fee & commission income slipped 39% to GBP9.7 million. The stockbroker's Corporate Finance and Research income declined 48% and 39%, respectively. Nomad & Broking income was broadly flat.

Cenkos recorded net trading gains of GBP900,000 in the first half, down 57% on the year before.

"As a result of the weak first half, revenue for the full year may be below that recorded in 2018; however the second half has started well with a number of transactions completed including an IPO," said Chief Executive Officer Jim Durkin.

Durkin continued: "This means Cenkos has completed two of only seven IPO's whose shares were admitted to trading on the AIM market in the period to August 2019, which demonstrates that Cenkos remains the leading AIM broker, raising money even in very difficult market conditions."

The stockbroker's administrative expenses cut by 38% to GBP10.9 million due to a 50% drop in staff costs as the company reduced its headcount.

Cenkos kept its interim dividend unchanged at 2.0 pence.

"Pipeline for the remainder of the year and for 2020 is encouraging. We continue to evolve our business to adapt to market changes and remain at the forefront in providing capital and solutions for growth companies," added CEO Durkin.

Separately, the stockbroker announced Paul Hodges and Joe Nally are stepping down from the company's board immediately.

Hodges, who runs Cenkos' equity capital markets team, and Nally, head of natural resources, will remain in place at Cenkos and as members of the company executive committee. The stockbroker said the move brings it into line with regulatory practices, with a resulting smaller board with a majority of non-executives.

More News
16 Dec 2015 12:40

DIRECTOR DEALINGS: Cenkos Chief Executive Durkin Adds To Stake

Read more
9 Dec 2015 18:00

DIRECTOR DEALINGS: Cenkos Says Durkin And Hodges Add To Holdings

Read more
8 Dec 2015 12:11

LONDON MARKET MIDDAY: Wary Eyes On BHP, Rio As Anglo Suspends Dividend

Read more
8 Dec 2015 10:40

WINNERS & LOSERS SUMMARY: Anglo American Sold As It Suspends Dividend

Read more
8 Dec 2015 09:04

Cenkos says not being investigated by SFO

(ShareCast News) - Stockbroker Cenkos Securities rallied after saying it was not being investigated by the Serious Fraud Office. The statement followed a report in the Sunday Times suggesting that the company had handed over a cache of documents to the SFO in relation to Watchstone Group, formerly k

Read more
8 Dec 2015 08:33

LONDON MARKET OPEN: Miners And Oil Firms Down As Anglo Gets "Radical"

Read more
8 Dec 2015 07:59

Cenkos Securities Says It Is Not Subject To SFO Investigation

Read more
25 Nov 2015 17:08

Cenkos To Buy Back 4.5 Million Shares Under GBP8 Million Tender Offer

Read more
30 Oct 2015 08:21

Cenkos Gets Started On GBP8.0 Million Return To Shareholders

Read more
22 Sep 2015 08:47

Cenkos Securities Profit Down On Lower AIM Activity In First Half

Read more
26 Jun 2015 10:34

Essenden Agrees To GBP40.1 Million Takeover Offer From Harwood Capital

Read more
15 Jun 2015 16:45

U.S. biotech company Evofem eyes London listing -sources

LONDON, June 15 (Reuters) - Biotech company Evofem is working with U.S. bank JP Morgan and British broker Cenkos on a London stock market listing aimed at raising about $200 million, three sources familiar with the matter said on Monday. San Diego-based Evofem, which specialises in women's

Read more
12 May 2015 08:25

Cenkos Securities Chairman Says Pipeline Remains Encouraging

Read more
7 May 2015 09:48

Verseon, Curtis Banks And MayAir Début On AIM (ALLIPO)

Read more
1 May 2015 11:28

DIRECTOR DEALINGS SUMMARY: Sweett Group Directors Buy 232,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.